Menu Item

Case study

Eli Lilly

Project Overview

Since our first project with Eli Lilly and Company (“Lilly”) in 2008, BLS & Co. has served as strategic advisor on multiple site selection and incentives advisory projects throughout the company’s real estate portfolio, involving over $8 billion in planned investment and 3,000 in announced new positions.

Project Highlights

  • Lebanon, Indiana (API & Gene Therapy Manufacturing)
  • Research Triangle Park, North Carolina (Injectables Manufacturing)
  • Concord, North Carolina (Injectables Manufacturing)
  • Boston, Massachusetts (R&D)
  • Limerick, Ireland (Biologics API Manufacturing)

Results

  • $8 billion in planned investment
  • 3,000 new jobs